Xtx Topco LTD Cidara Therapeutics, Inc. Transaction History

Xtx Topco LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$0.64 - $0.92 $52,509 - $75,482	-82,046 Reduced 50.94%	79,012 $72,000
Q4 2023 Feb 13, 2024	SELL	$0.68 - $0.97 $28,356 - $40,449	-41,700 Reduced 20.57%	161,058 $127,000
Q3 2023 Nov 13, 2023	SELL	$0.77 - $1.16 $189,712 - $285,800	-246,380 Reduced 54.86%	202,758 $190,000
Q2 2023 Aug 14, 2023	BUY	$1.01 - $1.42 $303,306 - $426,430	300,303 Added 201.77%	449,138 $507,000
Q1 2023 May 12, 2023	BUY	$0.75 - $1.98 $111,626 - $294,693	148,835 New	148,835 $189,000
Q1 2022 May 13, 2022	SELL	$0.67 - $1.39 $26,428 - $54,829	-39,446 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.18 - $2.18 $46,546 - $85,992	39,446 New	39,446 $50,000
Q3 2021 Nov 12, 2021	SELL	$1.48 - $2.35 $38,437 - $61,031	-25,971 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$1.87 - $2.7 $48,565 - $70,121	25,971 New	25,971 $52,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.43B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.